<DOC>
	<DOCNO>NCT02060864</DOCNO>
	<brief_summary>In trial , effect low high dose AN-PEP investigate gluten sensitive individual . Volunteers receive breakfast background ( 0.5 g ) gluten . Capsules take morning within 5 min start breakfast . Gastrointestinal fluid sample 3 hour measure gluten degradation . After 5 volunteer complete 3 test day , blind interim analysis perform third party base decide whether proceed low AN-PEP dose .</brief_summary>
	<brief_title>Effect AN-PEP Enzyme Gluten Digestion Gluten Sensitive Individuals</brief_title>
	<detailed_description />
	<criteria>Male/female Age â‰¥18 &lt; 70 yr Females : Hormonal contraceptive treatment Selfreported glutensensitive individual fulfil Rome III criterion consume gluten Subject read understood information provide study give write informed consent Coeliac disease serology consume gluten ( serological test tissue transglutaminase IgA antibodies total IgA antibody ) Wheat allergy ( serological test wheat protein IgE antibody ) Medication medical condition affect gastric empty secretion Females : Pregnancy breastfeed Inability swallow gastroduodenal feeding tube Any medical condition opinion investigator may interfere study may jeopardise health status participant Any condition opinion investigator may interfere study may jeopardise health status participant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>enzyme</keyword>
	<keyword>gluten</keyword>
	<keyword>food intolerance</keyword>
</DOC>